26 results on '"Afzali, Anita"'
Search Results
2. To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn’s Disease Patients
3. Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients
4. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned
5. Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting
6. Reply
7. Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.
8. IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS
9. Health Maintenance Consensus for Adults With Inflammatory Bowel Disease
10. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey
11. P169 DEFINITION OF REMISSION IN INFLAMMATORY BOWEL DISEASE: ASSESSMENT OF PATIENT AND PHYSICIAN PERSPECTIVES
12. To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn’s Disease Patients
13. Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients
14. P144 ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF THERAPY TO ADALIMUMAB, INFIXIMAB OR OTHER ANTI-TNF COMPARED WITH SWITCHING FROM ANTI-TNF THERAPY TO VEDOLIZUMAB
15. P136 CERTOLIZUMAB PEGOL IS EFFECTIVE IN THE MAINTENANCE OF RESPONSE IN MODERATE-SEVERE ULCERATIVE COLITIS: AN OPEN-LABEL MAINTENANCE STUDY
16. P089 PERCEPTIONS REGARDING USE OF ANTI-TUMOR NECROSIS FACTOR TREATMENTS FOR WOMEN OF CHILDBEARING AGE AMONG HEALTHCARE PROFESSIONALS
17. 28 CHARACTERISTICS AND OUTCOMES OF PROSPECTIVELY REPORTED PREGNANCIES EXPOSED TO CERTOLIZUMAB PEGOL FROM A SAFETY DATABASE
18. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned
19. Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol
20. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States
21. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease
22. P-101 Incidence of Anti-drug Antibodies in Crohnʼs Disease Patients During 5 Years of Certolizumab Pegol Therapy
23. P-039 YI Prevalence of Vitamin Deficiency in IBD and Its Association with Disease Activity in a Diverse Population Presenting to Establish Care
24. P-085 Evaluation of Switch in Rescue Agents
25. The association of psoriasis with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: A AQ1 single-center case series
26. Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.